Endoscopic healing and clinical remission after administration of adalimumab to patients with Crohn's disease of the small intestine

被引：0
|
作者：
Viazis, N. [1 ]
Koustenis, K. [1 ]
Veretanos, C. [1 ]
Mountaki, A. [1 ]
Almpani, F. [1 ]
Tsatsa, A. [1 ]
Trikola, A. [1 ]
Beka, H. [1 ]
Arvanitis, K. [1 ]
Georgiadi, T. [1 ]
Nousias, G. [1 ]
Mylonas, I. [1 ]
Kozompoli, D. [1 ]
Paparizou, N. [1 ]
Karaouzas, L. [1 ]
Papastergiou, V. [1 ]
Archavlis, E. [1 ]
Mela, M. [1 ]
Christidou, A. [1 ]
Varytimiadis, K. [1 ]
Hatzievangelinou, C. [1 ]
Katopodi, K. [1 ]
Vienna, E. [1 ]
Mantzaris, G. [1 ]
机构：
[1] Evangelismos Med Ctr, Gastroenterol, Athens, Greece
来源：
JOURNAL OF CROHNS & COLITIS | 2023年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P709
引用
收藏
页码：840 / 840
页数：1
相关论文
共 50 条
  • [21] Adalimumab induction and maintenance therapy achieve clinical remission and response in Chinese patients with Crohn's disease
    Wu, Kai-Chun
    Ran, Zhi Hua
    Gao, Xiang
    Chen, Minhu
    Zhong, Jie
    Sheng, Jian-Qiu
    Kamm, Michael A.
    Travis, Simon
    Wallace, Kori
    Mostafa, Nael M.
    Shapiro, Marisa
    Li, Yao
    Thakkar, Roopal B.
    Robinson, Anne M.
    INTESTINAL RESEARCH, 2016, 14 (02) : 152 - 163
  • [22] Cancer of the Small Intestine in Patients with Crohn's Disease
    Higashi, Daijiro
    Futami, Kitaro
    Kojima, Daibo
    Futatsuki, Ryo
    Ishibashi, Yukiko
    Maekawa, Takafumi
    Yano, Yutaka
    Takatsu, Noritaka
    Hirai, Fumihito
    Matsui, Toshiyuki
    Iwashita, Akinori
    ANTICANCER RESEARCH, 2013, 33 (07) : 2977 - 2980
  • [23] Remission and clinical response to open label adalimumab over one year in patients with Crohn's disease
    Hanauer, SB
    Lukas, M
    Macintosh, DG
    Pollack, PF
    Kent, J
    GUT, 2006, 55 : A15 - A15
  • [24] Adalimumab maintains clinical remission and response in patients with active Crohn's disease: Results of the CHARM trial
    Sandborn, William J.
    Colombel, J. F.
    Rutgeerts, P.
    Enns, R.
    Hanauer, S. B.
    Panaccione, R.
    Schreiber, S.
    Lomax, K. G.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S458 - S458
  • [25] Adalimumab Therapy Achieves Clinical Remission and Response at Week 26 in Chinese Patients with Crohn's Disease
    Wu, Kai-Chun
    Ran, Zhi Hua
    Gao, Xiang
    Chen, Minhu
    Zhong, Jie
    Sheng, Jian-Qiu
    Kamm, Michael A.
    Travis, Simon
    Robinson, Anne M.
    Wallace, Kori
    Shapiro, Marisa
    Li, Yao
    Thakkar, Roopal B.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 : S43 - S43
  • [26] Correlation Between Adalimumab Serum Levels and Remission After the Induction Phase in Crohn's Disease Patients
    Chaparro, Maria
    Guerra, Ivan
    Iborra, Marisa
    Nuno, Jose Luis Cabriada
    Taxonera, Luis Bujanda Carlos
    Garcia-Sanchez, Valle
    Marin-Jimenez, Ignacio
    Barreiro-de Acosta, Manuel
    Vera, Isabel
    Arranz, Maria Dolores Martin
    Hernandez-Breijo, Borja
    Mesonero, Francisco
    Sempere, Laura
    Nieto, Yolanda Ber
    Hinojosa, Joaquin
    Ramas, Mercedes
    Bermejo, Fernando
    Beltran, Belen
    Rodriguez-Lago, Iago
    Banales, Jesus
    Mendoza, Juan L.
    Aguilar-Melero, Patricia
    Menchen, Luis
    Ferreiro, Rocio
    Gomez, Isabel Blazquez
    Garcia, Beatriz Benitez
    Guijarro, Luis
    Linares, Pablo M.
    Gisbert, Javier P.
    GASTROENTEROLOGY, 2015, 148 (04) : S107 - S108
  • [27] Correlation between adalimumab serum levels and remission after the induction phase in Crohn's Disease patients
    Chaparro, M.
    Guerra, I.
    Iborra, M.
    Cabriada, J. L.
    Bujanda, L.
    Taxonera, C.
    Garcia-Sanchez, V.
    Marin-Jimenez, I.
    Barreiro de-Acosta, M.
    Vera, I.
    Martin-Arranz, M. D.
    Hernandez-Breijo, B.
    Mesonero, F.
    Sempere, L.
    Ber, Y.
    Hinojosa, M. D.
    Ramas, M.
    Bermejo, F.
    Beltran, B.
    Rodriguez-Lago, I.
    Banales, J. M.
    Mendoza, J. L.
    Aguilar-Melero, P.
    Menchen, L.
    Ferreiro, R.
    Blazquez, I.
    Benitez Garcia, B.
    Guijarro, L.
    Linares, P. M.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S395 - S395
  • [28] ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIMUMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN'S DISEASE PATIENTS
    Pellegatta, G.
    Lo Pumo, S.
    Bodini, G.
    Baldissarro, I.
    Giannini, E. G. B.
    Savarino, V.
    Jain, A.
    Savarino, E.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E135 - E135
  • [29] Administration Timing Is the Best Clinical Outcome Predictor for Adalimumab Administration in Crohn's Disease
    Mastronardi, Mauro
    Curlo, Margherita
    Cavalcanti, Elisabetta
    Burattini, Osvaldo
    Cuppone, Renato
    Tauro, Romina
    De Santis, Stefania
    Serino, Grazia
    Pesole, Pasqua Letizia
    Stasi, Elisa
    Caruso, Maria Lucia
    Donghia, Rossella
    Guerra, Vito
    Giorgio, Pietro
    Chieppa, Marcello
    FRONTIERS IN MEDICINE, 2019, 6
  • [30] Cost-effectiveness of adalimumab for the maintenance of remission in patients with Crohn's disease
    Loftus, Edward V., Jr.
    Johnson, Scott J.
    Yu, Andrew P.
    Wu, Eric Q.
    Chao, Jingdong
    Mulani, Parvez M.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (11) : 1302 - 1309
12345